Gene therapy competitive dynamics: Winner takes all?
This article was originally published in Cell & Gene. It has also been published in Cell & Gene‘s sister publication, OutSourced Pharama. With many gene...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Our focus areas
Trending topics
Engagements
- 01Evaluating the potential impact of cross-border healthcare for gene therapiesIssue Our client sought to understand the current state of healthcare across borders (also known as medical tourism) and the opportunities and risks this...View engagement
- 02Global pricing and access strategic issues assessment for rare diseases gene therapy portfolioIssue Our client is developing gene therapies for different rare disease indications, some with effective treatments available and others with only symptom...View engagement
- 03High-profile US patent litigation regarding HIV medicationsCRA was retained by plaintiffs ViiV Healthcare and other companies in their high-profile US patent litigation against Gilead Sciences, Inc., regarding HIV...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsRecent events
PMSA Annual Conference
Griff Vinton presents his co-authored paper titled “Building a Machine Learning Model to Find Undiagnosed Patients in Rare Disease.” For more information on...
ISPOR Accelerating Patient Access to Next Generation Sequencing in Oncology Webinar
Tim Wilsdon moderates the session discussing how to fast-track policy solutions that could address the barriers preventing patient access to NGS and identify...